Best-in-class analytics to evaluate the current opportunity of RPT eligible patients in the communities you serve

Evaluation of competitive dynamics, risks, and mitigation strategies

Financial impact assessments, pro forma development, and business case documentation

Engaging leadership and Board presentations to support decision making

Program staffing and resourcing recommendations for successful program development

Independent equipment procurement guidance aligned with your programmatic goals

Business office resources to help back-office teams integrate RPT into their workflow

Physical infrastructure guidance to help you design the best program for your practice and community

Phase 1-3 Radioligand Therapy Clinical Trials

SPECT/CT

Dosimetry

Identifying barriers to access to care unique to the communities you serve, including Medically Underserved Populations / Areas and rural communities

Advocacy support to further access to next generation therapeutics

Market-by-market research aggregation